PRELUDE CAPITAL MANAGEMENT, LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$5,195,00069,038
+627518.2%
0.15%
Q3 2019$0110.00%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q2 2022.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders